iACP

iACP predicts anticancer peptides (ACPs) from peptide primary sequences to identify candidate ACPs for cancer therapy research.

Key Features:

• Sequence-based prediction: Performs prediction of anticancer peptides (ACPs) using peptide primary sequence information.
• g-gap dipeptide optimization: Optimizes g-gap dipeptide components to enhance discriminative features for ACP classification.
• Cross-validation assessment: Evaluates model accuracy and stability through rigorous cross-validation.
• Comparative performance: Demonstrates superior accuracy and consistency relative to existing predictors as reported by cross-validation results.
• High-throughput prioritization: Prioritizes candidate ACPs from large peptide sequence datasets to accelerate downstream experimental validation.

Scientific Applications:

• Candidate identification: Prioritizes peptide sequences for experimental validation as anticancer peptides to support development of cancer therapeutics.
• Method benchmarking: Serves for comparative evaluation and benchmarking of ACP prediction methods.

Methodology:

Performs sequence-based prediction using optimized g-gap dipeptide components and assesses models via rigorous cross-validation.